ERK1/2 has also been shown to play a role in the development of injury following ischemia in the brain and heart [7,8,34,35], and ERK1/2 inhibitors have been shown to prevent pathological changes in the vasculature after stroke and ischemic heart disease [9,10]. This evidence concerns the gene MAPK3 and ischemia.